Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has launched Sodium Nitroprusside Injection, 50 mg/2 ml (25 mg/ml) Single-dose Vial, the therapeutic generic equivalent of Nitropress (sodium nitroprusside) Injection, 50 mg/2ml vial, approved by the U.S. Food and Drug Administration (USFDA).

The Nitropress brand and generics had U.S. sales of approximately $8 million MAT for the most recent twelve months ending in October 2019 according to IQVIA Health. The company’s Sodium Nitroprusside Injection is available in single-dose 50 mg/2 ml (25 mg/ml) vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.